Information about the 2019 Novel Coronavirus
The PARTNER Post Approval Study Part II
Trial ID or NCT#
The purpose of this post approval study is to determine the safety, effectiveness and learning curve of the SAPIEN™ THV with the Retroflex delivery system for Inoperable Patients and with the SAPIEN™ THV with Retroflex and Ascendra delivery systems for high risk operable patients with Severe Symptomatic Native Aortic Stenosis via all access sites.
The PARTNER II Trial "Placement of AoRTic TraNscathetER" Valves Trial" (US) [PII B] for Inoperable Patients
Contact us to find out if this trial is right for you.
Spectrum Child Health
About this Clinical Trial
Your Message Will Go ToSpectrum Child Health
To:Spectrum Child Health
Go Back To The Trial